The race to be the first to make a coronavirus vaccine is over, but that doesn’t mean the competition has ended. Inovio Pharmaceuticals(NASDAQ:INO) wasn’t exactly a contender for the top spot during the vaccine-development scramble in 2020. Its candidate,…

Click here to view the original article.